The Elements Steering Pathogenesis in IgG-Mediated Alloimmune Diseases.

Area of Science:

• Immunology
• Reproductive Medicine
• Transfusion Medicine

Background:

• Alloimmune diseases arise from antibodies targeting foreign cells, impacting pregnancy and blood transfusions.
• These antibodies, against antigens like HPA1-a, can cause severe fetal anemia or thrombocytopenia.
• Myeloid cells use IgG Fc-receptors (FcγR) to destroy antibody-targeted cells.

Purpose of the Study:

• To explore how IgG antibody induction and fetal inflammation influence FcγR effector functions.
• To discuss the role of IgG glycosylation, specifically low Fc-core fucosylation, in enhancing FcγR affinity and ADCC.
• To examine the synergistic effects of oxidative stress and acute phase responses (e.g., CRP) in allo- and autoimmune diseases.

Main Methods:

• Review and synthesis of recent studies on IgG antibodies, FcγR, and associated inflammatory factors.
• Analysis of IgG glycosylation patterns, particularly fucosylation, and their impact on FcγR binding.
• Investigation of the contribution of oxidative stress and C-reactive protein (CRP) to disease pathology.

Main Results:

• Low IgG-Fc-core fucosylation increases FcγRIIIa and FcγRIIIb affinity, enhancing antibody-dependent cellular cytotoxicity (ADCC) and phagocytosis.
• Fetal proinflammatory status significantly affects effector functions mediated by FcγR.
• Oxidative stress and CRP contribute to elevated disease pathology in alloimmune and autoimmune conditions.

Conclusions:

• IgG glycosylation, particularly fucosylation, is critical for FcγR-mediated immune responses in alloimmune diseases.
• Combined factors like inflammation, oxidative stress, and specific IgG modifications synergistically worsen disease outcomes.
• Understanding these mechanisms offers potential targets for managing pregnancy-related and transfusion-related alloimmune disorders.